Soleno Therapeutics Inc
SLNO
Market Cap$3.6B
Close$
$0.87
98.7% downside
Current Fair Value
98.7% downsideOvervalued by 98.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.60 Billion |
|---|---|
| Enterprise Value | $3.57 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.38 |
| Beta | -2.56 |
| Outstanding Shares | 50,483,281 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -18.87 |
|---|---|
| PEG | 24.05 |
| Price to Sales | - |
| Price to Book Ratio | 17.44 |
| Enterprise Value to Revenue | 109.4 |
| Enterprise Value to EBIT | -26.33 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Soleno Therapeutics Inc
CEO: Anish Bhatnagar